1)morphine sulfate sustained-releease tablets硫酸吗啡缓释片
英文短句/例句
1.The clinjcal analysis of morphine sulfate sustained-release tablets on cancer patients with serious pain硫酸吗啡缓释片治疗重度癌痛的临床疗效观察
2.Clinical Study of Morphine Sulfate Controlled-release Tablets in the Treatment of Cancer Pain;硫酸吗啡控释片治疗癌性疼痛的临床研究
3.Conparision of the effect of Oxycodone and Morphine controlled-release tablets in the treatment of visceral cancer pain盐酸羟考酮和硫酸吗啡控释片治疗癌性内脏痛的疗效比较
4.Clinical study on rectal administration of controlled-release tablet of morphine hydrochloride in the treatment of cancer pain盐酸吗啡缓释片经直肠给药治疗癌性疼痛的临床研究
5.A Clinical Observation of Controlled Release Morphine Sulphate (CRMS) for Pain Relief in Patients with Advanced Cancer硫酸吗啡控释片对晚期癌痛镇痛效果临床试验观察
6.Effect of Electro-acupuncture in Treating Morphine Sulfate Caused Constipation in Tumor Patients电针治疗肿瘤患者口服硫酸吗啡控释片所致便秘的临床研究
7.Releasing the cancer pain with morphine sulphate controlled-release tablets through orally and rectally administrations硫酸吗啡控释片口服与直肠给药控制癌性疼痛的临床观察
8.Preparation of ferrous sulfate sustained-release tablets复方硫酸亚铁缓释片的制备工艺优化
9.Morphine [Hydrochloride, Sulfate]吗啡[盐酸盐，硫酸盐]
10.Slow-release morphine and Chinese medicine Zhishu Decoction plus Buzhongyiqi Decoction for terminal cancerous pain盐酸吗啡缓释片联合枳术汤合补中益气汤加味治疗癌性疼痛的临床观察
11.An evaluation on effect and safety of morphine sulfate controlled-release tablet combined with celecoxib for the treatment of moderate to severe cancer-induced pain硫酸吗啡控释片联合塞来昔布个体化治疗中重度癌痛的临床疗效及安全性
12.Talcosis associated with intravenous abuse of oral morphine sulfate controlled-release tablets(one case report and literature review)静脉注射口服用硫酸吗啡控释片水溶液致滑石肺1例报告并文献复习
13.Release test of hydromorphone in two layers osmotic pump tablets盐酸氢吗啡酮双层渗透泵片的体外释放度考察
14.Effects of Self-made Sustained-release Alpha-lipoic Acid Tablet on Atherosclerosis自制α-硫辛酸缓释片对兔动脉粥样硬化的影响
15.Optimization of Determination Method of Gentamycin Sulfate Sustained-release Tablets硫酸庆大霉素缓释片含量测定方法探讨
16.Clinical observation of the curative effect and side effect of opiumism and Fentanyl pastes for middle and serious cancerous pain吗啡控缓释片及芬太尼贴剂治疗癌痛的临床观察
17.Preparation of Sustained-release Alpha-lipoic Acid Tablet and Its Pharmacodynamics in New Zealand Rabbits;α-硫辛酸缓释片的制备及其对新西兰兔药效学研究
18.Effects of Sustained-release Alpha-lipoic Acid Tablet on Blood Lipid, Blood Sugar and Insulin of Hyperlipidemic New Zealand Rabbits自制α-硫辛酸缓释片对高血脂新西兰兔血脂、血糖及胰岛素的影响
相关短句/例句
morphine hydrochloride sustained-release tablets盐酸吗啡缓释片
1.Objective To observe the analgesic effect of morphine hydrochloride sustained-release tablets on cancer patients at late stage.目的观察盐酸吗啡缓释片对晚期癌症的镇痛效果。
3)Morphine sulfate controlled-release tablets硫酸吗啡控释片
1.OBJECTIVE: To observe the short-term efficacy of Morphine sulfate controlled-release tablets(MS Contin) combined Compound kushen injection for cancer pain.目的:观察硫酸吗啡控释片(美施康定)联合复方苦参注射液治疗癌痛的近期疗效。
2.Objective: To observe the analgesic effect of morphine sulfate controlled-release tablets on cancer patients at late period.目的:观察硫酸吗啡控释片对晚期癌症镇痛的效果。
3.Objectives: To compare the analgesic effect and side effects between methadone hydrochloride tablets and morphine sulfate controlled-release tablets (MST).目的:比较美沙酮与硫酸吗啡控释片治疗中、重度癌痛的止痛效果和不良反应。
4)Morphine sustained release tablets吗啡缓释片
5)morphine hydrochloride sustained-release tablets(Morphine)盐酸吗啡缓释片(美菲康)
6)Morphine Sulfate Tablets硫酸吗啡片
延伸阅读
盐酸吗啡缓释片【通用名称】盐酸吗啡缓释片【其他名称】盐酸吗啡缓释片 盐酸吗啡缓释片 拼音名：Yansuan Mafei Huanshipian 英文名：MOrphine Hydrochloride Sustained-release Tablets 书页号：2000年版二部-588 本品含盐酸吗啡(C17H19NO3.HCl.3H2O)应为标示量的93.0％～107.0％。 【性状】本品为薄膜衣片，除去薄膜衣后显白色。 【鉴别】取本品，除去薄膜衣，研细，取细粉适量(约相当于盐酸吗啡20mg)，置乳钵中，加水 10ml，研磨 使盐酸吗啡溶解，滤过，滤液蒸干，残渣照盐酸吗啡项下的鉴别(1)、(2)、(3)、(5)项试验，显相同 的反应。 【检查】含量均匀度 取本品1片，置乳钵中，加水适量，研磨使盐酸吗啡溶解，转移至100ml (10mg规格) 或250ml(30mg规格)、500ml(60mg规格)量瓶中，用水分次洗涤乳钵，洗液并入量瓶中，充分振摇，加 水稀释至 刻度，摇匀，用0.45μm滤膜滤过，取续滤液，照含量测定项下的方法，自“精密量取续滤液”起，依 法测定含量，应符合规定(附录Ⅹ E)。 释放度 取本品，照释放度测定法(附录Ⅹ D 第一法)，采用溶出度测定法第一法装置，以水 500ml为溶 剂，转速为每分钟50转，依法操作，经1小时、2小时、3小时、4小时、5小时和6小时时，分别取溶液 2ml，用 0.45μm滤膜滤过，并及时在操作容器中补充相同温度的水2ml，取续滤液作为供试品溶液。另精密量 取含量 测定项下的对照品溶液适量，分别加流动相稀释成每1ml中含0.02mg(10mg规格)、0.05mg(30mg规 格)、 0.1mg(60mg规格)的溶液作为对照品溶液，照含量测定项下的方法分别测定峰面积，计算出每片在不同 时 间的释放量。本品每片在1小时、2小时、3小时、4小时、5小时和6小时时的释放量应分别相应为标示 量的 25％～45％、40％～60％、55％～75％、65％～85％、70％～90％和80％以上，均应符合规定。 其他 应符合片剂项下有关的各项规定(附录Ⅰ A)。 【含量测定】照高效液相色谱法(附录Ⅴ D)测定。 色谱条件与系统适用性试验 用十八烷基硅烷键合硅胶为填充剂；以0.05mol/L磷酸二氢钾溶液- 甲 醇(4:1)为流动相；检测波长为280nm。理论板数按吗啡峰计算应不低于1000。 测定法 取本品10片，精密称定，研细，精密称取适量(约相当于盐酸吗啡35mg)，置250ml量瓶 中，加 水适量，充分振摇使盐酸吗啡溶解，加水至刻度，摇匀，用0.45μm滤膜滤过，精密量取续滤液20μl注 入液相 色谱仪，记录色谱图；另精密称取经80℃干燥至恒重的吗啡对照品适量，加流动相制成每1ml中含 0.1mg的 溶液，同法测定。按外标法以峰面积计算，结果乘以1.317，即得供试品中C17H19NO3·HCl·3H2O的 量。 【类别】
【贮藏】同盐酸吗啡。 【规格】(1)10mg (2)30mg (3)60mg
